01 6ALPHARMA PHARMS
01 68623418
01 6Blank
01 6Blank
01 62029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
Patent Expiration Date : 2029-11-07
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8623418
Drug Substance Claim :
Drug Product Claim :
Application Number : 22321
Patent Use Code : U-1640
Delist Requested :
Patent Use Description : TREATMENT OF MODERATE ...
Patent Expiration Date : 2029-11-07
